Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Carboplatin and Pemetrexed in Advanced Non-Squamous K-ras Wild Type NSCLC
NCT01042288Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Jun 2010
- Primary completion
- Dec 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in non-small cell lung cancer (NSCLC), sponsored by SCRI Development Innovations. Started Jun 2010; status: completed.
02
Drugs
panitumumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01042288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01042288.